雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Gene Therapy and Viral Therapy for Malignant Glioma Kazuhiko KUROZUMI 1 , Shinichiro KOIZUMI 1 , Yoshihiro OTANI 2 1Department of Neurosurgery, Hamamatsu University School of Medicine 2Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Keyword: 悪性グリオーマ , 遺伝子治療 , 遺伝子細胞療法 , ウイルス療法 , 臨床試験 , malignant glioma , gene therapy , gene cell therapy , oncolytic viral therapy , clinical trial pp.608-616
Published Date 2021/5/10
DOI https://doi.org/10.11477/mf.1436204434
  • Abstract
  • Look Inside
  • Reference

 Malignant gliomas have a poor prognosis despite advances in surgical procedures, radiotherapy, and the emergence of new treatments have improved outcomes. One of these new treatments is gene therapy, which has been developed as a new therapeutic strategy. Recently, new methods and approaches have been developed. Gene therapy involves the introduction of genes or cells into a glioma, or the human body, to treat gliomas; various genes such as cancer-suppressing genes, immunomodulation cytokine-related genes, and suicide genes are used in this treatment. Viral therapy is a treatment that oncolytic viral replicates in tumor cells to destroy tumors. Various viral genes can also be used as therapeutic genes. Currently, the most well-studied and accumulated viruses are adenoviruses and HSV-1. Various clinical trials have been conducted using gene therapy and viral therapy, some of which are scheduled to be approved in the near future. Gene therapy and viral therapy have dramatically improved and have developed progressively since their first clinical use.


Copyright © 2021, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1251 印刷版ISSN 0301-2603 医学書院

関連文献

もっと見る

文献を共有